Intellia Therapeutics
NTLA
#5139
Rank
A$1.98 B
Marketcap
$19.48
Share price
0.83%
Change (1 day)
-56.16%
Change (1 year)

Intellia Therapeutics (NTLA) - Cash on Hand

Cash on Hand as of September 2024 : A$1.05 Billion

According to Intellia Therapeutics's latest financial reports the company has A$1.05 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Intellia Therapeutics - Cash on Hand chart (from 2015 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$1.33 B-23.6%
2022-12-31A$1.75 B69.71%
2021-12-31A$1.03 B32.93%
2020-12-31A$0.77 B94.45%
2019-12-31A$0.39 B-10.38%
2018-12-31A$0.44 B2.16%
2017-12-31A$0.43 B15.19%
2016-12-31A$0.37 B264%
2015-12-31A$0.10 B765.14%
2014-12-31A$12.02 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.43 B-58.61%๐Ÿ‡บ๐Ÿ‡ธ USA